10-Q: MariMed Inc. Reports Third Quarter 2024 Results, Revenue Up 4.6% Year-Over-Year

MariMed Inc. reports a 4.6% increase in revenue for the third quarter of 2024 compared to the same period last year, driven by wholesale growth.

Summary

• MariMed Inc. reported a revenue increase of 4.6% for the third quarter of 2024, reaching $40.6 million, compared to $38.8 million in the same period of 2023.
• The company's wholesale revenue saw a significant increase of 19.5%, while retail revenue decreased by 3.1% in the third quarter.
• For the nine months ended September 30, 2024, total revenue was $119 million, an 8.4% increase compared to $109.7 million in the same period of 2023.
• The company's gross profit was $16.8 million for the third quarter and $50.2 million for the nine-month period.
• MariMed reported a net loss of $1 million for the third quarter and a net loss of $3.96 million for the nine-month period.
• The company completed two acquisitions in the nine months ended September 30, 2024, Allgreens Dispensary, LLC and Our Community Wellness & Compassionate Care Center, Inc.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with revenue growth offset by a net loss and increased operating expenses. The company is actively expanding through acquisitions, but faces challenges in retail sales and other revenue streams. The sentiment is neutral to slightly negative.

Positives

• Wholesale revenue experienced substantial growth, increasing by 19.5% in the third quarter and 33.2% for the nine-month period.
• The company successfully completed two acquisitions, expanding its footprint in Illinois and Maryland.
• The new credit facility provides financial flexibility and reduces interest expenses.
• The company's management fees increased significantly, by 410.8% in the third quarter and 764.8% for the nine-month period.

Negatives

• Retail revenue decreased by 3.1% in the third quarter and 3.2% for the nine-month period.
• The company reported a net loss of $1 million for the third quarter and $3.96 million for the nine-month period.
• Real estate rental income decreased by 49.4% in the third quarter and 37.8% for the nine-month period.
• Licensing fees decreased by 35.9% for the nine-month period.

Risks

• The company's financial performance is subject to changes in demand for its services and products.
• Changes in laws and their enforcement could impact the company's operations.
• The company faces risks related to the timing and outcome of regulatory processes.
• Changes in the economic environment could affect the company's financial results.
• The company is subject to legal claims from time to time.
• The company is subject to the risk of fraud, as evidenced by a $0.7 million loss due to a fraudulent email.

Future Outlook

The company anticipates devoting substantial capital resources to continue its efforts to execute its strategic growth plan, including acquisitions and expansion of its product distribution.

Management Comments

• Management believes that Adjusted EBITDA is a useful measure to assess the company's performance and liquidity.
• Management uses Adjusted EBITDA to understand and compare operating results across accounting periods, and for financial and operational decision-making.

Industry Context

The company operates in the rapidly evolving cannabis industry, which is subject to changing regulations and market conditions. The company's performance is influenced by the legalization of cannabis in various states and the increasing acceptance of cannabis products.

Comparison to Industry Standards

• The company's revenue growth of 4.6% in the third quarter is moderate compared to some other multi-state operators in the cannabis industry, which have seen higher growth rates.
• The company's net loss indicates that it is still in a growth phase and is investing in expansion and acquisitions.
• The company's focus on wholesale revenue growth aligns with industry trends, as wholesale channels are becoming increasingly important for cannabis companies.
• The company's adjusted EBITDA is a key metric used by investors and analysts to compare financial results across accounting periods and to those of peer companies.

Corporate Governance

Legal Proceedings

• There has been no material change to the status of the company's previously reported legal proceedings.

Related Party Transactions

• The company leases its corporate offices from an entity in which the CEO has an investment interest.
• The company procures nutrients, lab equipment, cultivation supplies, furniture, and tools from an entity owned by the family of the COO.
• The company pays royalties on the revenue generated from its Bettys Eddies product line to an entity owned by the COO and CRO.
• One of the company's majority-owned subsidiaries paid distributions to the CEO, who owns a minority equity interest in such subsidiary.
• The CEO and COO purchased membership units of Mari Holdings Metropolis, LLC.
• The company holds a 49% interest in a delivery company that delivers products purchased at certain of the company's dispensaries.
• The company's mortgages with Bank of New England and DuQuoin State Bank were personally guaranteed by the CEO.

Stakeholder Impact

• Shareholders may be concerned about the net loss reported for the quarter and the nine-month period.
• Employees may be affected by the company's expansion and hiring activities.
• Customers may benefit from the company's expanded product offerings and retail locations.
• Suppliers may see increased business opportunities as the company expands its operations.
• Creditors may be interested in the company's debt levels and ability to meet its obligations.

Next Steps

• The company will continue to focus on executing its strategic growth plan.
• The company will prioritize activities that include completing the acquisition of First State Compassion Center.
• The company will increase revenue organically in states where it currently does business.
• The company will expand its footprint into high-growth legal cannabis states.
• The company will increase product brand revenue by introducing new products and expanding distribution.

Key Dates

Keywords

cannabis, marijuana, multi-state operator, dispensary, cultivation, wholesale, retail, acquisitions, financial results, revenue, EBITDA, licenses